Antimicrobial nanocapsules: from new solvent-free process to in vitro efficiency by Steelandt J, Salmon D, Gilbert E, Almouazen E, Renaud FNR, Roussel L, Haftek M, Pirot F

Get full text

Vaccine breakthrough hypoxemic COVID-19 pneumonia in patients with auto-Abs neutralizing type I IFNs by Bastard, P, Vazquez, SE, Liu, J, Laurie, MT, Wang, CY, Gervais, A, Le Voyer, T, Le Voyer, T, Bizien, L, Zamecnik, C, Philippot, Q, Rosain, J, Catherinot, E, Willmore, A, Mitchell, AM, Bair, R, Garçon, P, Kenney, H, Fekkar, A, Salagianni, M, Poulakou, G, Siouti, E, Sahanic, S, Tancevski, I, Weiss, G, Nagl, L, Manry, J, Duvlis, S, Arroyo-Sánchez, D, Paz Artal, E, Rubio, L, Perani, C, Bezzi, M, Sottini, A, Quaresima, V, Roussel, L, Vinh, DC, Reyes, LF, Garzaro, M, Hatipoglu, N, Boutboul, D, Tandjaoui-Lambiotte, Y, Borghesi, A, Aliberti, A, Cassaniti, I, Venet, F, Monneret, G, Halwani, R, Sharif-Askari, NS, Danielson, J, Constantinescu, S